These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17353398)

  • 1. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis.
    Kano OI; Arasaki K; Ikeda K; Iwasaki Y
    Arch Neurol; 2007 Mar; 64(3):458-9; author reply 459. PubMed ID: 17353398
    [No Abstract]   [Full Text] [Related]  

  • 2. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Gordon PH; Cheung YK
    Neurology; 2006 Oct; 67(7):1314-5; author reply 1314-5. PubMed ID: 17030785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amyotrophic lateral sclerosis in Baranya county, Hungary].
    Merkli H; Nagy F; Pál E; Gáti I; Kovács N; Komoly S; Illés Z
    Ideggyogy Sz; 2006 Nov; 59(11-12):406-8. PubMed ID: 17203876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misdiagnosis in patients with amyotrophic lateral sclerosis.
    Belsh JM; Schiffman PL
    Arch Intern Med; 1990 Nov; 150(11):2301-5. PubMed ID: 2241438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of amyotrophic lateral sclerosis].
    Bufler J
    MMW Fortschr Med; 2007 May; 149 Suppl 2():84-7. PubMed ID: 17724975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India.
    Nalini A; Thennarasu K; Gourie-Devi M; Shenoy S; Kulshreshtha D
    J Neurol Sci; 2008 Sep; 272(1-2):60-70. PubMed ID: 18550082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin. A clue to modifying genetic factors?
    Drory VE; Artmonov I
    J Neurol Sci; 2007 Jul; 258(1-2):39-43. PubMed ID: 17408694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictability of disease progression in amyotrophic lateral sclerosis.
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Muscle Nerve; 2006 Dec; 34(6):702-8. PubMed ID: 16967489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
    Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
    J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole.
    Paillisse C; Lacomblez L; Dib M; Bensimon G; Garcia-Acosta S; Meininger V
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):37-44. PubMed ID: 16036424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis.
    Peysson S; Vandenberghe N; Philit F; Vial C; Petitjean T; Bouhour F; Bayle JY; Broussolle E
    Eur Neurol; 2008; 59(3-4):164-71. PubMed ID: 18230874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis.
    Drory VE; Bronipolsky T; Artamonov I; Nefussy B
    J Neurol Sci; 2008 Oct; 273(1-2):81-3. PubMed ID: 18678378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression and survival in ALS: first multi-state model approach.
    Gil J; Preux PM; Alioum A; Ketzoian C; Desport JC; Druet-Cabanac M; Couratier P
    Amyotroph Lateral Scler; 2007 Aug; 8(4):224-9. PubMed ID: 17653920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.
    Vender RL; Mauger D; Walsh S; Alam S; Simmons Z
    Amyotroph Lateral Scler; 2007 Feb; 8(1):36-41. PubMed ID: 17364434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study.
    Murphy M; Quinn S; Young J; Parkin P; Taylor B
    Neurology; 2008 Dec; 71(23):1889-95. PubMed ID: 19047561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival prediction and related risk factors of amyotrophic lateral sclerosis:analysis of 65 cases].
    Qiao L; Zhang J; Fan DS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):742-5. PubMed ID: 18683681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A contribution on the clinical aspects and incidence of amyotrophic lateral sclerosis. (Isolated and familial cases)].
    Lorez A
    Schweiz Med Wochenschr; 1969 Jan; 99(2):51-7. PubMed ID: 5767383
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease-modifying drug therapies.
    Brooks BR; Sanjak M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():68-75. PubMed ID: 15512878
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G
    J Neurol Sci; 2008 May; 268(1-2):28-32. PubMed ID: 18021808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.